|
News Feed Item
Corcept Therapeutics Announces Presentations on Mifepristone for the Treatment of Patients with Hypercortisolism at the American Association of Clinical Endocrinologists 26th Annual Congress
|
By Marketwired . |
Article Rating: |
|
May 4, 2017 08:30 AM EDT |
|
|
MENLO PARK, CA -- (Marketwired) -- 05/04/17 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced that presentations about hypercortisolism and mifepristone's role in treating that disorder will be presented at the 26th Annual Congress of the American Association of Clinical Endocrinologists (AACE) being held at the Austin Convention Center in Austin, Texas.
"There is growing awareness that even less severe degrees of hypercortisolism are harmful," said Joseph K. Belanoff, M.D., Corcept's Chief Executive Officer. "As a result, physicians are increasingly screening patients whose metabolic and cardiovascular symptoms have not responded to conventional therapy and finding cases of previously undetected Cushing's syndrome."
In addition to viewing the posters described below, AACE attendees may attend "Evolving Paradigms of Hypercortisolism," a product theater talk by Ty Carroll, M.D. Corcept is a sponsor of the talk.
----------------------------------------------------------------------------
Thursday, May 4, 2017
----------------------------------------------------------------------------
Poster #124
Screening of Diabetic Patients Using
U500
Insulin Uncovers a High Percentage of Joseph W. Mathews, M.D., FACE
Undiagnosed Hypercortisolism James J. Smith, PhD
Consistent
with Cushing Syndrome
----------------------------------------------------------------------------
Friday, May 5, 2017, 12:45 - 1:30pm
Product Theater B
----------------------------------------------------------------------------
Evolving Paradigms of
Hypercortisolism Ty Carroll, M.D.
----------------------------------------------------------------------------
Friday, May 5, 2017
----------------------------------------------------------------------------
Poster #131
Medical Management of Mild
Hypercortisolism and Primary
Aldosteronism in a Patient with Sandi-Jo Galati, M.D.
ACTH-Independent Macronodular Michele Lamerson, RN, MS, CPNP
Hyperplasia
Presenting with Resistant
Hypertension
----------------------------------------------------------------------------
Adriana G. Ioachimescu, M.D., PhD, FACE
Poster #608 Jonathan G. Ownby, M.D., FACE
Improving Glycemic Control with Nicole G. Greyshock, M.D., FACE
Mifepristone Thomas C. Jones, M.D., FACE
in Cushing Syndrome Patients May Lead Gary S. Wand, M.D., PhD, FACE
to Significant Weight-loss James J. Smith, PhD
----------------------------------------------------------------------------
Poster #725
Successful Medical Management with Saima Farghani, M.D.
Mifepristone in a Patient with Occult Michele Lamerson, RN, MS, CPNP
Ectopic Cushing Syndrome
----------------------------------------------------------------------------
Poster #836
Mifepristone Therapy Significantly
Improved
Insulin Resistance, Glycemic Control, Jonathan G. Ownby, M.D., FACE
and Weight Loss in a Patient with James J. Smith, PhD
Cushing Disease
Previously Treated with Pasireotide
----------------------------------------------------------------------------
Poster #839
Mifepristone Reduced U500 Insulin
Usage in a Patient with Cushing Kimberley A. Bourne, M.D., FACE
Disease and Normalized Concomitant James J. Smith, PhD
Fatty Liver Disease and Retinopathy
----------------------------------------------------------------------------
About Corcept Therapeutics Incorporated
Corcept is a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol. Korlym®, a first-generation cortisol modulator, is the company's first FDA-approved medication. The company has a portfolio of proprietary compounds that modulate the effects of cortisol but not progesterone. Corcept owns extensive intellectual property covering the use of cortisol modulators, including mifepristone, in the treatment of a wide variety of serious disorders, including Cushing's syndrome. It also holds composition of matter patents covering its selective cortisol modulators.
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.
Latest Stories By Yeshim Deniz  In this presentation, you will learn first hand what works and what doesn't while architecting and deploying OpenStack. Some of the topics will include:- best practices for creating repeatable deployments of OpenStack- multi-site considerations- how to customize OpenStack to integrate with your existing systems and security best practices. Apr. 22, 2018 04:45 AM EDT Reads: 1,399 | By Pat Romanski  As you move to the cloud, your network should be efficient, secure, and easy to manage. An enterprise adopting a hybrid or public cloud needs systems and tools that provide: Agility: ability to deliver applications and services faster, even in complex hybrid environments
Easier manageability: enable reliable connectivity with complete oversight as the data center network evolves
Greater efficiency: eliminate wasted effort while reducing errors and optimize asset utilization Security: implemen... Apr. 22, 2018 04:30 AM EDT Reads: 4,101 | By Liz McMillan  Your homes and cars can be automated and self-serviced. Why can't your storage? From simply asking questions to analyze and troubleshoot your infrastructure, to provisioning storage with snapshots, recovery and replication, your wildest sci-fi dream has come true.
In his session at @DevOpsSummit at 20th Cloud Expo, Dan Florea, Director of Product Management at Tintri, provided a ChatOps demo where you can talk to your storage and manage it from anywhere, through Slack and similar services with... Apr. 22, 2018 04:15 AM EDT Reads: 5,931 | By Elizabeth White  Most people haven’t heard the word, “gamification,” even though they probably, and perhaps unwittingly, participate in it every day.
Gamification is “the process of adding games or game-like elements to something (as a task) so as to encourage participation.” Further, gamification is about bringing game mechanics – rules, constructs, processes, and methods – into the real world in an effort to engage people.
In his session at @ThingsExpo, Robert Endo, owner and engagement manager of Intrepid D... Apr. 22, 2018 04:00 AM EDT Reads: 17,236 | By Liz McMillan  Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service.
However, the benefit of WebRTC for IoT is not only its convenience and interopera... Apr. 22, 2018 03:00 AM EDT Reads: 3,786 | By Liz McMillan  Evan Kirstel is an internationally recognized thought leader and social media influencer in IoT (#1 in 2017), Cloud, Data Security (2016), Health Tech (#9 in 2017), Digital Health (#6 in 2016), B2B Marketing (#5 in 2015), AI, Smart Home, Digital (2017), IIoT (#1 in 2017) and Telecom/Wireless/5G. His connections are a "Who's Who" in these technologies, He is in the top 10 most mentioned/re-tweeted by CMOs and CIOs (2016) and have been recently named 5th most influential B2B marketeer in the US. H... Apr. 22, 2018 02:30 AM EDT Reads: 2,752 | By Yeshim Deniz  Michael Maximilien, better known as max or Dr. Max, is a computer scientist with IBM. At IBM Research Triangle Park, he was a principal engineer for the worldwide industry point-of-sale standard: JavaPOS. At IBM Research, some highlights include pioneering research on semantic Web services, mashups, and cloud computing, and platform-as-a-service. He joined the IBM Cloud Labs in 2014 and works closely with Pivotal Inc., to help make the Cloud Found the best PaaS. Apr. 22, 2018 02:15 AM EDT Reads: 1,943 | By Elizabeth White  Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning. Apr. 22, 2018 01:30 AM EDT Reads: 6,748 | By Liz McMillan  "With Digital Experience Monitoring what used to be a simple visit to a web page has exploded into app on phones, data from social media feeds, competitive benchmarking - these are all components that are only available because of some type of digital asset," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY. Apr. 22, 2018 01:15 AM EDT Reads: 5,117 | By Liz McMillan  Everything run by electricity will eventually be connected to the Internet. Get ahead of the Internet of Things revolution. In his session at @ThingsExpo, Akvelon expert and IoT industry leader Sergey Grebnov provided an educational dive into the world of managing your home, workplace and all the devices they contain with the power of machine-based AI and intelligent Bot services for a completely streamlined experience. Apr. 22, 2018 01:00 AM EDT Reads: 3,747 | By Pat Romanski  "This week we're really focusing on scalability, asset preservation and how do you back up to the cloud and in the cloud with object storage, which is really a new way of attacking dealing with your file, your blocked data, where you put it and how you access it," stated Jeff Greenwald, Senior Director of Market Development at HGST, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY. Apr. 22, 2018 12:45 AM EDT Reads: 15,902 | By Elizabeth White  "Venafi has a platform that allows you to manage, centralize and automate the complete life cycle of keys and certificates within the organization," explained Gina Osmond, Sr. Field Marketing Manager at Venafi, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Apr. 22, 2018 12:45 AM EDT Reads: 5,216 | By Elizabeth White  Creating replica copies to tolerate a certain number of failures is easy, but very expensive at cloud-scale. Conventional RAID has lower overhead, but it is limited in the number of failures it can tolerate. And the management is like herding cats (overseeing capacity, rebuilds, migrations, and degraded performance). In his general session at 18th Cloud Expo, Scott Cleland, Senior Director of Product Marketing for the HGST Cloud Infrastructure Business Unit, discussed how a new approach is neces... Apr. 22, 2018 12:30 AM EDT Reads: 7,514 | By Liz McMillan  Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive... Apr. 22, 2018 12:15 AM EDT Reads: 2,575 | By Pat Romanski  "We're developing a software that is based on the cloud environment and we are providing those services to corporations and the general public," explained Seungmin Kim, CEO/CTO of SM Systems Inc., in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Apr. 22, 2018 12:00 AM EDT Reads: 3,717 |
|
|
|
|
|
|